Alison D. Schecter, an experienced biotech executive, shares insights and advice on leadership in the biotech industry. She discusses the importance of understanding both the science and commercial aspects of biotech businesses. Schecter emphasizes the value of hands-on experience in clinical trials and the ability to understand the language and challenges of the field. She also highlights the significance of building relationships, fostering an innovative culture, and maintaining transparency and respect within the organization. Schecter shares her experiences navigating challenges, including the impact of COVID-19 on clinical trials.